Author

R. Sahu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Organism:human· 1 Assay:multiome· 1

Frequent Co-Authors

K. C. Murmu· 2 shared K. K. Jena· 2 shared N. R. Chauhan· 2 shared P. Prasad· 2 shared S. Chauhan· 2 shared S. K. Das· 2 shared S. Mehto· 2 shared A. Datey· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

K. C. Murmu

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

HuR enhances SARS-CoV-2 non-structural protein translation through the genomic 5'-UTR, by promoting polypyrimidine tract-binding protein binding

H. Raheja, R. Sahu, T. Ghosh, P. Rani, B. George, O. Khatun, S. Tripathi, S. Das

This paper identifies HuR's role in enhancing SARS-CoV-2 non-structural protein translation via the 5'-UTR by promoting PTB binding, while suppressing structural protein translation, and shows potential therapeutic targeting of HuR.

bioRxiv · Mar 15, 2023Microbiology

Transgenic Mouse Models Establish a Protective Role of Type 1 IFN Response in SARS-CoV-2 infection-related Immunopathology

N. R. Chauhan, S. Kundu, R. Bal, D. Chattopadhyay, S. Mehto, R. Sahu, R. Yadav, S. Krishna, K. K. Jena, S. Satapathy, K. C. Murmu, B. Singh, S. K. Das, S. Jena, K. H. Harshan, , S. Chauhan

This study uses transgenic mouse models to show that a heightened type 1 IFN response protects against SARS-CoV-2-induced immunopathology, with Irgm1 as a potential therapeutic target.

bioRxiv · Dec 17, 2022 · PreprintImmunology

Autoimmunity Risk Gene IRGM is a Master Negative Regulator of Interferon Response by Controlling the Activation of cGAS STING and RIG-I-MAVS Signaling Pathways

K. K. Jena, S. Mehto, P. Nath, N. R. Chauhan, R. Sahu, T. K. Nayak, S. K. Das, K. Dhar, P. K. Sahoo, K. C. Murmu, S. De, A. Datey, P. Prasad, S. Chattopadhyay, S. Chauhan, S. Chauhan

This study identifies IRGM as a negative regulator of interferon response by controlling cGAS-STING and RIG-I-MAVS pathways, linking its deficiency to autoimmunity and antiviral resistance.

bioRxiv · Oct 22, 2019 · PreprintImmunology